‘Immense’ change prompts new guideline to address salvage therapy for prostate cancer

The American Urological Association, in collaboration with other organizations, released a clinical practice guideline on salvage therapy for men with prostate cancer. The guideline includes 30 recommendations for treating men with localized disease who experienced PSA recurrence after definitive local therapy. The guidelines cover various topics such as treatment decision-making, assessment, and management of recurrence…

Read More

Physical activity lowers cardiovascular disease risk by reducing stress-related brain activity, study finds

New research led by Massachusetts General Hospital shows that physical activity can reduce cardiovascular disease risk by reducing stress-related brain activity. The study looked at over 50,000 participants and found that those who met physical activity recommendations had a 23% lower risk of developing cardiovascular disease. Physical activity was found to be twice as effective…

Read More

Single Low-Dose Esketamine Injection May Reduce Postpartum Depression In New Mothers: Study

Postpartum depression affects around 20% of women, causing symptoms like mood swings, fatigue, and anxiety. It is treatable with therapy or medication. A recent study found that a single low-dose injection of esketamine immediately after birth reduced the risk of postpartum depression by 75% in those with prenatal depression. Esketamine, derived from ketamine, is approved…

Read More

Ultra-Low-Temperature Cryoablation promising in Treatment of Ventricular Tachycardias: Study

A study has found that ultra-low-temperature cryoablation is a promising treatment for ventricular tachycardias. This technique involves using extreme cold to destroy abnormal heart tissue that causes the condition. The study suggests that this approach could be effective in treating ventricular tachycardias. Further research is needed to better understand the potential benefits of this treatment….

Read More

The New Radiopharma Competition Requires Unprecedented Medical Logistics

AstraZeneca’s recent acquisition of a radiopharmaceutical partner highlights the rapid growth of the radiopharmaceutical market, which is expected to reach $13.7 billion by 2032. Radiopharmaceutical therapies target cancer cells with radioactive drugs and offer potential life-saving benefits for cancer patients. Challenges in delivering radioligand therapy include the need for accurate diagnostics, short half-lives of medicines,…

Read More
error: Content is protected !!